Latest News & Features
Big Pharma
Increasing numbers of patent challengers are finding the USPTO’s post-grant procedures to be attractive alternatives to district court litigation, write Arlene Chow and Peter Noh. 29 September 2014
Americas
A trade deal between the EU and Canada, due to be signed today if last-minute German concerns can be overcome, would have implications for pharmaceutical IP protection and could raise the cost of drugs in Canada, a report has claimed. 26 September 2014
Americas
A US court has ordered medical technology company Boston Scientific Corporation to pay $309 million to the family of the late physician Michel Mirowski in the latest chapter of their long running patent dispute. 26 September 2014
Asia
Law firm Miller, Canfield, Paddock & Stone has expanded its IP team in China with the appointment of life sciences specialist Kening Li. 24 September 2014
Americas
Generic drug maker Par Pharmaceutical Companies has settled a long running dispute with Salix Pharmaceuticals over its heartburn drug Zegerid (omeprazole/sodium bicarbonate). 23 September 2014
Biotechnology
UK-based cancer drug company Sareum has been granted a patent for an invention forming part of its treatment methods. 22 September 2014
Asia
Indian drug maker Cipla has signed a deal with Salix Pharmaceuticals allowing the US-based company exclusive rights relating to the Rifaximin Complexes patent family. 19 September 2014
Asia
US biotechnology company Gilead has agreed a licensing deal with seven Indian drug makers that will enable them to sell a generic version of a drug used to treat hepatitis C. 17 September 2014
Asia
Biopharmaceutical company Epirus has said that India’s drug regulator has approved a biosimilar application to produce a version of a popular arthritis treatment drug. 16 September 2014
Big Pharma
A newly revealed malware could be looking to attack the pharmaceutical sector in order to steal IP, a report has claimed. 15 September 2014